Abstract:Background Ovarian cancer (OC) has the highest fatality rate amongst all gynecologic malignancies. Exploring new factors and pathways associated with development of ovarian cancer would help to identify new therapeutic targets. Long non-coding RNAs (lncRNAs) play indispensable roles in the process of the progression of OC. Methods Reverse transcription-quantitative PCR (RT-qPCR) was performed to verify the expression of RAD51B-AS1 in cell lines and patients’ tissues. Cellular proliferation, metastasis and apoptosis were detected using Cell Counting Kit-8(CCK-8), colony formation, Transwell and flow cytometry assays, respectively. Mouse xenograft models were established to detect tumorigenesis. RT-qPCR, western blotting and immunofluorescence experiments were conducted to explore the quantitative and positional relationship between RAD51B-AS1 and its host gene, RAD51B. Co-transfection rescue experiments were then performed to preliminarily explore its mechanism in vivo and in vitro. Results RAD51B-AS1 was significantly upregulated in a highly metastatic human OC cell line and in OC tissues. RAD51B-AS1 significantly increased the proliferation and metastasis of OC cells, whilst also enhancing resistance to anoikis. Biogenetics prediction analysis revealed that the only target gene of RAD51B-AS1 was RAD51B. Subsequent gene function experiments revealed that RAD51B exerted the same biological effects as RAD51B-AS1. Rescue experiments demonstrated that the malignant biological behaviors promoted by RAD51B-AS1 overexpressing were partially or completely reversed by RAD51B silencing in vitro and in vivo.Conclusion RAD51B-AS1 promoted the malignant biological behavior of OC, and the underlying mechanism of this action may be associated with the positive regulation of RAD51B expression. The present study revealed a potentially novel molecular mechanism underlying the development of OC. RAD51B-AS1 is expected to serve as a novel molecular biomarker for the diagnosis and prediction of a poor prognosis in OC, and as a potential therapeutic target for management of the disease.

RHPN1-AS1 Promotes Cell Proliferation and Migration Via Mir-665/Akt3 in Ovarian Cancer

Long Non-Coding RNA UCA1 Regulates SRPK1 Expression Through Mir-99B-3p in Ovarian Cancer.

Long Non-Coding RNA RHPN1-AS1 Promotes Tumorigenesis and Metastasis of Ovarian Cancer by Acting As a Cerna Against Mir-596 and Upregulating LETM1.

PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis

Mir-532–3P Suppresses Proliferation and Invasion of Ovarian Cancer Cells Via GPNMB/HIF-1α/HK2 Axis

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

LncRNA RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer via upregulation of RAD51B

Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression

Upregulation of Mir-614 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Suppressing PPP2R2A Expression

Overexpression Of Mirna-221 Promotes Cell Proliferation By Targeting The Apoptotic Protease Activating Factor-1 And Indicates A Poor Prognosis In Ovarian Cancer

MicroRNA-196a Promotes Cell Proliferation and Inhibits Apoptosis in Human Ovarian Cancer by Directly Targeting DDX3 and Regulating the PTEN/PI3K/AKT Signaling Pathway

HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3

HOXD-AS1 Promotes Cell Proliferation, Migration and Invasion Through Mir-608/Fzd4 Axis in Ovarian Cancer.

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer

Long Non‐coding RNA SNHG1 Stimulates Ovarian Cancer Progression by Modulating Expression of Mir‐454 and ZEB1

Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis

miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.

Long Non-Coding RNA OIP5-AS1 Promotes Proliferation of Gastric Cancer Cells by Targeting Mir-641

MicroRNA-1179 Regulates Proliferation and Chemosensitivity of Human Ovarian Cancer Cells by Targeting the PTEN-mediated PI3K/AKT Signaling Pathway

Mir-638 Suppresses Proliferation by Negatively Regulating High Mobility Group A1 in Ovarian Cancer Cells.